8-K/A filed May 28, 2024, 7:59 PM ET CIK 0001962918

leadership confidence high sentiment neutral materiality 0.65

ACELYRIN names Mina Kim CEO; Kim gets $640k base, 1.2M option grant; ex-CEO Lin severance disclosed

ACELYRIN, Inc.

Mina Kim appointed CEO effective May 9, 2024, and to Board; Shao-Lee Lin stepped down as CEO and Board member.
Lin receives severance: 18 months base salary, equity vesting acceleration, pro-rated 2024 bonus, up to 24 months health premiums.
Kim's annual base salary $640,000, target bonus 55% of base, and option to purchase 1,195,856 shares under 2023 EIP.
Ron Oyston steps down as Chief People Officer effective Aug 15, 2024; gets 12 months salary continuation, COBRA, equity vesting.
Kim previously served as Chief Legal and Administrative Officer; background includes Zymergen, Atara, Sunrun.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ron Oyston

Chief People Officer

ACELYRIN, Inc.

Effective: 2024-08-15
Filed: May 28, 2024, 7:59 PM ET

the Company and Ron Oyston mutually agreed that Mr. Oyston will step down from his position as Chief People Officer, effective August 15, 2024.

Appointed

Mina Kim

Director

ACELYRIN, Inc.

Effective: 2024-05-09
Filed: May 28, 2024, 7:59 PM ET

and was appointed as a member of the Board of Directors of the Company

Role change

Mina Kim

Chief Executive Officer

ACELYRIN, Inc.

Effective: 2024-05-09
Filed: May 28, 2024, 7:59 PM ET

Effective May 9, 2024, Mina Kim was appointed as the Chief Executive Officer of the Company

Departed

Shao-Lee Lin, M.D., Ph.D.

Chief Executive Officer

ACELYRIN, Inc.

Effective: 2024-05-08
Successor: Mina Kim
Filed: May 28, 2024, 7:59 PM ET

By mutual agreement of Shao-Lee Lin, M.D., Ph.D. and the Company, Dr. Lin stepped down from her position as Chief Executive Officer and as a member of the Board, effective on May 8, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ron Oyston departed as Chief People Officer at ACELYRIN, Inc..

Action: step down
Role: Chief People Officer

Exact text from the filing

the Company and Ron Oyston mutually agreed that Mr. Oyston will step down from his position as Chief People Officer, effective August 15, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mina Kim was appointed as Director at ACELYRIN, Inc..

Action: appointed
Role: Director

Exact text from the filing

and was appointed as a member of the Board of Directors of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mina Kim was appointed as Chief Executive Officer at ACELYRIN, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

Effective May 9, 2024, Mina Kim was appointed as the Chief Executive Officer of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Shao-Lee Lin, M.D., Ph.D. departed as Chief Executive Officer at ACELYRIN, Inc..

Action: stepped down
Role: Chief Executive Officer

Exact text from the filing

By mutual agreement of Shao-Lee Lin, M.D., Ph.D. and the Company, Dr. Lin stepped down from her position as Chief Executive Officer and as a member of the Board, effective on May 8, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001962918-24-000075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.